-
-
Overview
-
N1-(2-aminophenyl)-N8-phenyloctanediamide
BML-210 is a novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 mM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.Please contact us at for specific academic pricing.
-
- Properties
- Applications
-
Overview